DETERMINATION OF THE ACUTE TOXICITY (LD50) OF A GLYCYRRHETINIC ACID DERIVATIVE IN MICE: AN IMRAD-BASED ANALYTICAL ARTICLE USING SIX PEER-REVIEWED STUDIES WITH VERIFIED DOI NUMBERS

Аннотация

Acute toxicity assessment remains the first indispensable in vivo step in the preclinical development of semisynthetic glycyrrhetinic acid (GA) derivatives. Determination of the median lethal dose (LD50) in mice, together with close observation of behavioral, autonomic, neurological, biochemical, and histopathological signs of intoxication, provides the toxicological basis for selecting pharmacologically relevant dose ranges for subsequent anti-inflammatory, antitumor, hepatoprotective, or antimicrobial studies. The aim of the present article was to prepare an IMRAD-format analytical paper on the topic “Determination of the acute toxicity (LD50) of a glycyrrhetinic acid derivative in mice” using six original or primary-source peer-reviewed publications and safety papers with real and verifiable DOI numbers. The paper was designed not as a fictional experimental report but as a dissertation-oriented analytical model showing how an acute-toxicity study of a glycyrrhetinic acid derivative should be justified, structured, interpreted, and connected with the wider glycyrrhetinic acid literature.